Automated hiPSC Expansion

About Unicorn Biotechnologies

Unicorn Biotechnologies is a private, early-revenue stage platform company founded in 2018 and headquartered in Cambridge, UK. It has developed 'Emmet,' a benchtop robotic system that automates cell culture workflows, with a primary focus on iPSC expansion and differentiation to address critical bottlenecks in R&D and manufacturing for cell therapies. The company targets research scientists and laboratory managers, offering both hardware and protocol development services to enhance reproducibility and scalability while reducing labor and contamination risks. Its strategy positions it as an enabler for the broader cell therapy industry rather than a therapeutic developer itself.

Other Cell Therapy Manufacturing Enabling Technology Drugs